Efficacy of Daratumumab-Based Regimens for the Treatment of Plasma Cell Leukemia

被引：7

作者：

Parrondo, Ricardo D. ^{[1
]}

Moustafa, Muhamad Alhaj ^{[1
]}

Reeder, Craig ^{[2
]}

Sher, Taimur ^{[1
]}

Roy, Vivek ^{[1
]}

Muchtar, Eli ^{[3
]}

Warsame, Rahma ^{[3
]}

Alegria, Victoria ^{[1
]}

Gonsalves, Wilson ^{[3
]}

Dingli, David ^{[3
]}

Hayman, Suzanne ^{[3
]}

Kapoor, Prashant ^{[3
]}

Chanan-Khan, Asher A. ^{[1
]}

Ailawadhi, Sikander ^{[1
]}

机构：

[1] Mayo Clin, Div Hematol Oncol, 4500 San Pablo Rd,Mangurian Bldg 3rd Floor, Jacksonville, FL 32224 USA

[2] Mayo Clin, Div Hematol Oncol, Phoenix, AZ USA

[3] Mayo Clin, Div Hematol, Rochester, MN USA

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2021年 / 21卷 / 05期

关键词：

Immunotherapy; Monoclonal antibodies; Multiple myeloma; Plasma cell dyscrasias; Targeted therapy; DEXAMETHASONE; CRITERIA;

D O I：

10.1016/j.clml.2021.01.002

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：355 / 360

页数：6

共 19 条

[1] Daratumumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: extended follow-up of POLLUX, a randomized, open-label, phase 3 study
Bahlis, Nizar J.
Dimopoulos, Meletios A.
White, Darrell J.
Benboubker, Lotfi
Cook, Gordon
Leiba, Merav
Ho, P. Joy
Kim, Kihyun
Takezako, Naoki
Moreau, Philippe
Kaufman, Jonathan L.
Krevvata, Maria
Chiu, Christopher
Qin, Xiang
Okonkwo, Linda
Trivedi, Sonali
Ukropec, Jon
Qi, Ming
San-Miguel, Jesus
[J]. LEUKEMIA, 2020, 34 (07) : 1875 - 1884
[2] Extramedullary multiple myeloma
Bhutani, Manisha
Foureau, David M.
Atrash, Shebli
Voorhees, Peter M.
Usmani, Saad Z.
[J]. LEUKEMIA, 2020, 34 (01) : 1 - 20
[3] Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma
Dimopoulos, M. A.
Oriol, A.
Nahi, H.
San-Miguel, J.
Bahlis, N. J.
Usmani, S. Z.
Rabin, N.
Orlowski, R. Z.
Komarnicki, M.
Suzuki, K.
Plesner, T.
Yoon, S. -S.
Ben Yehuda, D.
Richardson, P. G.
Goldschmidt, H.
Reece, D.
Lisby, S.
Khokhar, N. Z.
O'Rourke, L.
Chiu, C.
Qin, X.
Guckert, M.
Ahmadi, T.
Moreau, P.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (14) : 1319 - 1331
[4] Apollo: Phase 3 Randomized Study of Subcutaneous Daratumumab Plus Pomalidomide and Dexamethasone (D-Pd) Versus Pomalidomide and Dexamethasone (Pd) Alone in Patients (Pts) with Relapsed/Refractory Multiple Myeloma (RRMM)
Dimopoulos, Meletios A.
Terpos, Evangelos
Boccadoro, Mario
Delimpasi, Sosana
Beksac, Meral
Katodritou, Eirini
Moreau, Philippe
Baldini, Luca
Symeonidis, Argiris
Bila, Jelena
Oriol, Albert
Mateos, Maria-Victoria
Einsele, Hermann
Orfanidis, Ioannis
Ahmadi, Tahamtan
Ukropec, Jon
Kampfenkel, Tobias
Schecter, Jordan
Qiu, Yanping
Amin, Himal
Vermeulen, Jessica
Carson, Robin
Sonneveld, Pieter
[J]. BLOOD, 2020, 136
[5] Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group
Fernandez de Larrea, C.
Kyle, R. A.
Durie, B. G. M.
Ludwig, H.
Usmani, S.
Vesole, D. H.
Hajek, R.
San Miguel, J. F.
Sezer, O.
Sonneveld, P.
Kumar, S. K.
Mahindra, A.
Comenzo, R.
Palumbo, A.
Mazumber, A.
Anderson, K. C.
Richardson, P. G.
Badros, A. Z.
Caers, J.
Cavo, M.
Leleu, X.
Dimopoulos, M. A.
Chim, C. S.
Schots, R.
Noeul, A.
Fantl, D.
Mellqvist, U-H
Landgren, O.
Chanan-Khan, A.
Moreau, P.
Fonseca, R.
Merlini, G.
Lahuerta, J. J.
Blade, J.
Orlowski, R. Z.
Shah, J. J.
[J]. LEUKEMIA, 2013, 27 (04) : 780 - 791
[6] Trends in survival of patients with primary plasma cell leukemia: a population-based analysis
Gonsalves, Wilson I.
Rajkumar, S. Vincent
Go, Ronald S.
Dispenzieri, Angela
Gupta, Vinay
Singh, Preet P.
Buadi, Francis K.
Lacy, Martha Q.
Kapoor, Prashant
Dingli, David
Lust, John A.
Zeldenrust, Steven R.
Hayman, Suzanne R.
Kyle, Robert A.
Gertz, Morie A.
Kumar, Shaji K.
[J]. BLOOD, 2014, 124 (06) : 907 - 912
[7] Secondary plasma cell leukemia: a multicenter retrospective study of 101 patients
Jurczyszyn, Artur
Castillo, Jorge J.
Avivi, Irit
Czepiel, Jacek
Davila, Julio
Vij, Ravi
Fiala, Mark A.
Gozzetti, Alessandro
Grzasko, Norbert
Milunovic, Vibor
Hus, Iwona
Madry, Krzysztof
Waszczuk-Gajda, Anna
Usnarska-Zubkiewicz, Lidia
Debski, Jakub
Atilla, Erden
Beksac, Meral
Mele, Giuseppe
Sawicki, Waldemar
Jayabalan, David
Charlinski, Grzegorz
Szabo, Agoston Gyula
Hajek, Roman
Delforge, Michel
Kopacz, Agnieszka
Fantl, Dorotea
Waage, Anders
Crusoe, Edvan
Hungria, Vania
Richardson, Paul
Laubach, Jacob
Guerrero-Garcia, Thomas
Liu, Jieqi
Vesole, David H.
[J]. LEUKEMIA & LYMPHOMA, 2019, 60 (01) : 118 - 123
[8] Real-world data on prognosis and outcome of primary plasma cell leukemia in the era of novel agents: a multicenter national study by the Greek Myeloma Study Group
Katodritou, Eirini
Terpos, Evangelos
Delimpasi, Sossana
Kotsopoulou, Maria
Michalis, Eurydiki
Vadikolia, Chrysanthi
Kyrtsonis, Marie-Christine
Symeonidis, Argiris
Giannakoulas, Nikolaos
Vadikolia, Chrissa
Michael, Michalis
Kalpadakis, Christina
Gougopoulou, Theodora
Prokopiou, Chrystalla
Kaiafa, Georgia
Christoulas, Dimitrios
Gavriatopoulou, Maria
Giannopoulou, Evlampia
Labropoulou, Vasiliki
Verrou, Evgenia
Kastritis, Efstathios
Konstantinidou, Pavlina
Anagnostopoulos, Achilles
Dimopoulos, Meletios A.
[J]. BLOOD CANCER JOURNAL, 2018, 8
[9] PLASMA-CELL LEUKEMIA - REPORT ON 17 CASES
KYLE, RA
MALDONADO, JE
BAYRD, ED
[J]. ARCHIVES OF INTERNAL MEDICINE, 1974, 133 (05) : 813 - 817
[10] Survival outcomes of patients with primary plasma cell leukemia (pPCL) treated with novel agents
Mina, Roberto
Joseph, Nisha S.
Kaufman, Jonathan L.
Gupta, Vikas A.
Heffner, Leonard T.
Hofmeister, Craig C.
Boise, Lawrence H.
Dhodapkar, Madhav, V
Gleason, Charise
Nooka, Ajay K.
Lonial, And Sagar
[J]. CANCER, 2019, 125 (03) : 416 - 423

← 1 2 →